CURRENT OPINION IN INFECTIOUS DISEASES

Scope & Guideline

Transforming Knowledge into Practice in Infectious Diseases

Introduction

Explore the comprehensive scope of CURRENT OPINION IN INFECTIOUS DISEASES through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore CURRENT OPINION IN INFECTIOUS DISEASES in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0951-7375
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1988 to 2024
AbbreviationCURR OPIN INFECT DIS / Curr. Opin. Infect. Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

CURRENT OPINION IN INFECTIOUS DISEASES is dedicated to providing comprehensive insights into the evolving landscape of infectious diseases, focusing on contemporary challenges, diagnostic advancements, and innovative therapeutic strategies. The journal emphasizes multidisciplinary approaches and the integration of cutting-edge research to enhance clinical practice.
  1. Infectious Disease Management and Treatment:
    The journal covers a wide array of infectious diseases, detailing current treatment options, management strategies, and emerging therapies for various infections. This includes bacterial, viral, fungal, and parasitic infections, with a particular emphasis on multidrug-resistant pathogens.
  2. Diagnostic Innovations:
    A significant focus is placed on advancements in diagnostic methods, including molecular diagnostics, artificial intelligence, and machine learning applications that enhance the accuracy and speed of infectious disease diagnosis.
  3. Infection Prevention and Control:
    The journal addresses strategies and controversies in infection prevention, particularly in vulnerable populations such as immunocompromised patients, pregnant women, and the elderly, highlighting best practices and challenges in clinical settings.
  4. Epidemiological Insights:
    CURRENT OPINION IN INFECTIOUS DISEASES provides analyses on epidemiological trends and public health implications of infectious diseases, including the impact of global issues like climate change and pandemics on infection dynamics.
  5. Host-Pathogen Interactions:
    Research on the interactions between hosts and pathogens, including immune responses and the implications for treatment and prevention strategies, is a core area of focus, contributing to a deeper understanding of infection biology.
Recent publications in CURRENT OPINION IN INFECTIOUS DISEASES have revealed several emerging themes that reflect the current challenges and advancements in the field of infectious diseases. These trends indicate a dynamic response to global health crises and evolving scientific knowledge.
  1. Impact of COVID-19 on Infectious Disease Practices:
    The ongoing influence of the COVID-19 pandemic has led to a surge in research focused on its implications for infectious disease management, prevention strategies, and the long-term effects on patients, particularly those with comorbidities.
  2. Integration of Artificial Intelligence and Machine Learning:
    There is a notable increase in publications discussing the application of AI and machine learning in diagnostics, treatment planning, and infection control, highlighting the journal's commitment to embracing innovative technologies in healthcare.
  3. Focus on Vulnerable Populations:
    Emerging research emphasizes the challenges faced by vulnerable populations, such as the immunocompromised, pregnant women, and marginalized communities, reflecting a growing recognition of health disparities in infectious disease outcomes.
  4. Resilience Against Antimicrobial Resistance (AMR):
    Research addressing strategies to combat antimicrobial resistance, including novel therapeutics and stewardship programs, is gaining traction, underscoring the urgency of this global health threat.
  5. Exploration of the Microbiome's Role in Disease:
    An increasing number of studies are investigating the microbiome's impact on health and disease susceptibility, indicating a trend towards understanding complex host-pathogen interactions and their clinical implications.

Declining or Waning

As the field of infectious diseases evolves, certain themes and topics have shown a decline in publication frequency or prominence within the journal. This can reflect shifts in research priorities or the successful resolution of previously pressing issues.
  1. Traditional Antibiotic Stewardship Approaches:
    While antibiotic stewardship remains critical, there has been a noticeable decline in discussions surrounding traditional approaches, possibly due to the emergence of more innovative methods and technologies, such as machine learning and precision medicine.
  2. Basic Research in Non-Clinical Settings:
    There appears to be a waning focus on basic research that does not directly translate into clinical practice or public health policy, as the journal increasingly prioritizes studies with immediate clinical relevance.
  3. Generalized Vaccination Strategies:
    The journal has shifted away from broad discussions of vaccination strategies in favor of more targeted analyses, particularly regarding specific populations or emerging infectious threats, suggesting a decline in interest in generalized vaccination discussions.

Similar Journals

Infectious Disease Reports

Empowering insights into the world of infectious diseases.
Publisher: MDPIISSN: Frequency: 6 issues/year

Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.

Transplant Infectious Disease

Empowering researchers to tackle transplant-related infections with cutting-edge insights.
Publisher: WILEYISSN: 1398-2273Frequency: 6 issues/year

Transplant Infectious Disease is a premier journal dedicated to advancing the understanding of infectious complications in transplant recipients, contributing significantly to the fields of Infectious Diseases and Transplantation. Published by Wiley in the United Kingdom, this journal boasts an impressive reputation within the academic community, holding a 2023 Q2 quartile ranking in both Infectious Diseases and Transplantation, as well as notable Scopus rankings that position it among the top tiers of its categories. With a convergence of scholarly articles and research findings from 1999 through 2024, Transplant Infectious Disease serves as a critical resource for researchers, professionals, and students seeking to explore the intersection of transplantation and infectious diseases. The journal encourages open dialogue and knowledge dissemination through rigorous peer-reviewed content, making it an essential platform for those aiming to address the challenges and innovations in transplant medicine.

Hepatitis Monthly

Transforming insights into impactful clinical practices.
Publisher: BRIEFLANDISSN: 1735-143XFrequency: 12 issues/year

Hepatitis Monthly, published by BRIEFLAND in the Netherlands, is a pivotal journal in the fields of hepatology and infectious diseases. Established in 2007, it continues to make significant contributions to the understanding and management of hepatitis and related viral infections with a publication timeline extending through to 2024. Aiming to disseminate high-quality research, the journal serves as a forum for groundbreaking studies and innovations essential for healthcare professionals, researchers, and students alike. While it currently holds Q4 rankings in both hepatology and infectious disease categories, its ongoing commitment to addressing pressing health issues makes it an important resource in the academic community. Although it operates under a traditional access model, Hepatitis Monthly not only publishes original research articles, reviews, and case studies but also encourages the exchange of knowledge that helps shape future research directions and clinical practices. As it continues to explore the complexities surrounding viral hepatitis, this journal invites researchers to contribute to its mission of advancing scientific understanding and improving patient care.

Current Clinical Microbiology Reports

Catalyzing Progress in the Fight Against Infections
Publisher: SPRINGERISSN: 2196-5471Frequency: 4 issues/year

Current Clinical Microbiology Reports, published by Springer, is a leading international journal dedicated to advancing the field of clinical microbiology. With a focus on the diagnosis, treatment, and prevention of infectious diseases, this journal serves as a vital resource for researchers, medical professionals, and students engaged in microbiological studies. As a testament to its quality and influence, it holds an impressive impact factor and ranks in the Q1 category in both Infectious Diseases and Microbiology (medical), reflecting its prominent standing in the scholarly community. Additionally, it features a commendable Scopus ranking, placing it in the 77th percentile for Medicine - Infectious Diseases and the 69th percentile for Medicine - Microbiology (medical). With contributions spanning over a decade, from 2014 to 2024, the journal continues to publish high-quality research articles that shape the future of clinical practices and public health policies. While access options are variable, the journal's commitment to open dialogue and dissemination of knowledge makes it a pivotal platform for those passionate about tackling microbial challenges in healthcare.

AVIAN PATHOLOGY

Advancing avian health through cutting-edge research.
Publisher: TAYLOR & FRANCIS LTDISSN: 0307-9457Frequency: 6 issues/year

AVIAN PATHOLOGY is a leading academic journal published by Taylor & Francis Ltd, focusing on the field of avian health, diseases, and diagnostics. With an ISSN of 0307-9457 and an E-ISSN of 1465-3338, this esteemed journal has been serving the scientific community since its inception in 1972, with content converging until 2024. Notably recognized in the 2023 Journal Rank, it holds a Q1 category in Animal Science and Zoology, making it an essential source for researchers and practitioners alike. The journal emphasizes critical insights into avian pathology, fostering significant advancements in veterinary science and poultry health management. Although it is not open access, subscriptions provide access to high-impact reviews and original research that underpin vital practices in the industry. With its prestigious publishing lineage and impactful scope, AVIAN PATHOLOGY continues to be a cornerstone for those dedicated to understanding and improving the health of avian species worldwide.

JOURNAL OF INFECTION

Driving Progress in the Fight Against Infectious Diseases
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

INTERVIROLOGY

Uncovering breakthroughs in virology and infectious diseases.
Publisher: KARGERISSN: 0300-5526Frequency: 6 issues/year

INTERVIROLOGY is a leading academic journal dedicated to advancing the field of virology and infectious diseases, published by KARGER. With a commendable history since its inception in 1973, the journal is currently poised to explore innovative virological research through to 2024. INTERVIROLOGY is indexed with the ISSN 0300-5526 and E-ISSN 1423-0100, reflecting its commitment to maintaining high scholarly standards. The journal is categorized within the Q3 quartile for both Infectious Diseases and Virology as of 2023, demonstrating its relevance and contribution to the academic community. With Scopus rankings placing it as #130 in Infectious Diseases and #41 in Virology, INTERVIROLOGY serves as an essential resource for researchers, professionals, and students seeking cutting-edge insights and discoveries in virology. While it currently operates under a subscription model, its rigorous peer-review process ensures a high quality of published content, making it a cornerstone for those dedicated to understanding and combating viral diseases.

Jundishapur Journal of Microbiology

Bridging theory and practice in the realm of microbiology.
Publisher: BRIEFLANDISSN: 2008-3645Frequency: 12 issues/year

Welcome to the Jundishapur Journal of Microbiology, a peer-reviewed publication dedicated to advancing the field of microbiology. Published by BRIEFLAND, this journal focuses on key areas such as infectious diseases and medical microbiology, offering a platform for researchers to share their findings from 2009 to 2024. Despite its current positioning in Quartile 4 across various categories in 2023, the journal provides a valuable resource for budding scientists and established professionals alike, contributing to the growing body of knowledge in these critical areas. While it is not an open-access journal, the Jundishapur Journal prioritizes the dissemination of research in the Netherlands, facilitating a deeper understanding of microbial science and its implications for public health. Join a community of innovators committed to exploring both emerging and established themes in microbiology.

INTERNATIONAL JOURNAL FOR PARASITOLOGY

Connecting Researchers to the Heart of Parasitology
Publisher: ELSEVIER SCI LTDISSN: 0020-7519Frequency: 14 issues/year

International Journal for Parasitology, published by Elsevier Sci Ltd, stands as a premier platform for disseminating groundbreaking research in the fields of parasitology and infectious diseases. With an impressive impact factor represented by its Q1 quartile rankings in both Infectious Diseases and Parasitology for 2023, this journal commands significant attention within the scientific community. Operating since 1971, it has profoundly contributed to the understanding of parasitic infections and their implications for human health, occupying a distinguished position ranked #7 out of 79 in Parasitology and #64 out of 344 in Infectious Diseases according to Scopus metrics. Although the journal currently does not offer open access options, it ensures rigorous peer review and unparalleled academic integrity, providing researchers, professionals, and students with critical insights necessary for advancing knowledge and fostering innovations in parasitology. Together with its rich historical foundation and commitment to excellence, the journal is indispensable for anyone delving into the complexities of parasites and their impact on both host and ecosystem.

MIKROBIYOLOJI BULTENI

Exploring Innovations in Infectious Disease Research
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.